College of Engineering at VCU set to offer new Ph.D. program in computer science
Published Saturday, Feb. 20, 2021, 10:54 am
Join AFP s 100,000+ followers on Facebook
Purchase a subscription to AFP | Subscribe to AFP podcasts on iTunes
News, press releases, letters to the editor: augustafreepress2@gmail.com
Front Page » Local/State » Local2 » College of Engineering at VCU set to offer new Ph.D. program in computer science
The College of Engineering at Virginia Commonwealth University will offer a new doctoral program in computer science.
This program reflects the Department of Computer Science’s robust growth in research funding and scholarship. It follows new doctoral programs in pharmaceutical engineering (a joint program with the School of Pharmacy) and chemical and life science engineering.
Civica Inc. To Invest $124M To Build New Manufacturing Facility In Virginia
Pharmaceutical manufacturer Civica Inc. will invest $124.5M to establish its first in-house pharmaceutical manufacturing operation in Petersburg, Virginia. The company plans to create 186 new jobs.
Civica is a nonprofit generic drug company launched in 2018 to address the problem of chronic generic drug shortages and high drug prices, and a key partner for the new U.S. government-funded partnership with Phlow Corporation, Medicines for All Institute, and AMPAC Fine Chemicals.
Through this partnership, Phlow executed a $354M contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to produce essential medications using advanced manufacturing processes from the Medicines for All Institute based at the College of Engineering at Virginia Commonwealth University (VCU).
Civica announces plans to manufacture generic drugs in commonwealth Shawna De La Rosa | Jan 21, 2021
Share this:
The pharmaceutical firm Civica will invest $124.5 million to establish its first in-house pharmaceutical manufacturing operation in the Petersburg, a venture that will create 186 jobs. The nonprofit generic drug company launched in 2018 to address the problem of chronic generic drug shortages and high prices.
It is a partner in the government-funded Phlow Corporation, Medicines for All Institute and AMPAC Fine Chemicals affiliation. Phlow executed a $354 million Medicines for All Institute contract with the U.S. Biomedical Advanced Research and Development Authority to produce essential medications using advanced manufacturing processes. Medicines for All Institute is based out of the College of Engineering at Virginia Commonwealth University.